Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
WuXi PharmaTech Receives $3.2 Billion Privatization Offer | April 30, 2015
Shenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV Drug | April 27, 2015
Shanghai Haohai Biological to Stage $305 Million IPO in Hong Kong | April 21, 2015>> See all top stories...
ChinaBio® in the News